For core bond investors, these funds track the Bloomberg Barclays U.S. Aggregate Bond Index.
Lewis Kaufman, manager of Artisan Developing World, talks about his approach to emerging-markets investing.
Here's a look at Interpublic Group and Clorox, which were recently added to the Morningstar Dividend Yield Focus Index.
We expect modest auto market growth this year, with GM and Adient as standouts.
Mark Miller breaks down the differences between traditional Medicare and Medicare Advantage.
Alex Bryan discusses two picks for investors that should hold up over the long term.
Russ Kinnel shares some ideas that provide a sense of calm.
Corporate boards are paying more attention to diversity, but the percentage of female fund managers continues to stall.
Fines and new regulations are likely for both firms, but the political upheaval in an election year puts Facebook more in peril.
We discuss what makes these stocks appealing right now.
Amid the coronavirus outbreak, our DBRS Morningstar analyst explains what we're looking for with production in China.
There are several things to consider first.
Karin Anderson discusses some choices from the core and core-plus intermediate-term bond category.
This firm's shares are currently undervalued pending its acquisition of Anixter. We suggest buying in before the market realizes the potential of this combined entity.
Christine Benz explains what investors should do amid market turbulence.
These diverse funds have earned their first Morningstar Analyst Ratings.
Russ Kinnel offers a range of suggestions for those looking for a new holding.
Christine Benz discusses how the SECURE Act affects required minimum distributions.
Christine Benz has some tips for those trying to squeeze in a contribution for the 2019 tax year.
Two main concerns for investors are overblown.
Longtime successful managers Bill Nygren and David Herro anchor this firm's stellar lineup of funds.
Russ Kinnel discusses the importance of the People Pillar in assessing a Morningstar Analyst Rating and a few funds that are exceptional in this area.
Intuit maintains its wide moat thanks to subscription transition and connected products.
Gilead, Intel, and Citigroup look to maintain consistent growth and steady futures.
We see some opportunity for investment, especially in Merck.
Investment demand is expected to drop.
Morningstar Prospects showcases 11 new funds with promising futures ahead.
Foreign stocks and stock funds have underperformed the U.S. for a long time, but change is inevitable.
An ESG frame helps us bring a better look at valuation within the healthcare sector.
Christine Benz explains the tax advantages of health savings accounts, if you're eligible.
But the market continues to punish this wide-moat company, providing an attractive entry point for investors.
And the three names we believe are best positioned.
There's still time to make contributions to an IRA for the 2019 tax year. Christine Benz shares some investment ideas to consider before tax day.
Both have pros and cons, but in today's environment, this is no longer an either-or prospect for investors, who should instead consider total shareholder yield.
The earnings power of brands like Corona and Modelo along with catalysts on the horizon make this wide-moat firm an underappreciated gem in the brewing industry.
Russ Kinnel discusses three rating upgrades, two rating downgrades, and some details about Morningstar's revised ratings.
Christine Benz discusses some of the steps we should be taking now to make sure we're prepared.
Wait for a pullback in the sector, which currently has one of its highest price/fair value ratios since 2007.
Income-oriented investors should keep an eye on Macerich, Park Hotels & Resorts, and Ventas.
Morningstar's Karen Andersen explains how ESG issues affect Big Pharma and biotech companies.
These blend, value, and growth options can serve a valuable role in a diversified portfolio.
Our latest research looks at how banks might be affected at this point in the economic cycle.
Investors need to do some sleuthing to understand how much risk they are taking on.
Christine Benz discusses her key takeaways from the annual projections issued by several investment firms.
Having fewer holdings to monitor allows you to stay focused on more important issues.
Determining your risk capacity and risk tolerance can help get you in the right ballpark for your stock/bond mix.
Consider these strategies to help you decide how much to withdraw from your portfolio.